These findings highlight the ERα-ERRα-SPP1 pathway as a key player in radiation-induced breast cancer risk, providing a potential target for developing protective therapies to safeguard female astronauts during deep-space missions. This evidence concerns the gene ESRRA and breast carcinoma.